GlassScriptPhysician profile
Nisha Patel
NPI 1558744813
$2,569.45
in general payments reported to CMS, 2019-2025
10 companies · $890 in 2025
The $890 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.98 · 2022: $732 · 2023: $542 · 2024: $326 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,651.60 | 2021-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $290.14 | 2022-2025 | |
| Axsome Therapeutics, INC. | $268.27 | 2022-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $114.48 | 2024-2025 | Lumryz |
| Lilly USA, LLC | $87.79 | 2025 | Zepbound, Mounjaro |
| Azurity Pharmaceuticals, INC. | $39.89 | 2024 | Horizant, Edarbi |
| Fisher & Paykel Healthcare INC | $37.39 | 2024-2025 | Fisher & Paykel Healthcare |
| Idorsia Pharmaceuticals US INC | $32.21 | 2023-2024 | Quviviq |
| Janssen Pharmaceuticals, INC | $30.39 | 2023 | Opsumit |
| Boston Scientific Corporation | $17.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.